A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Yakucari, a job search website for pharmacists. The company also provides online lectures; clinical trial; research targeting domestic medical professionals; medical-related self-planned data and research reports; global health professional research; survey panel provision services; and m3.com opening and management services. In addition, it offers AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides services for pharmaceutical companies; and drug information database. Further, the company is involved in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; Support for recruiting subjects necessary for clinical development and clinical research, and related tasks; provision of management support to medical institutions, as well as visiting nursing, day care, and home care support services; and operates podiatry and venous disease clinics, and hospice facilities. Additionally, it offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Financial Summary
| Share Statistics | MTHRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7,354.7 | $200.5 | 73% |
|
| Shares Out (Mil) | 4.2 | 47.8 | 12% |
|
| Institutional Ownership | 46.2% | 79.0% | 20% |
|
| Float (Mil) | 356.3 | 39.8 | 82% |
|
| Beta | na | 1.17 | na |
|
| Avg Daily Volume (000s) | 160 | 331 | 41% |
|
| Price Change (52-week) |
(30.8%) | 44.9% | 23% |
|
| Growth | MTHRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.6% | 11.8% | 48% |
|
| Net Income (5yr) | (2.0%) | 2.7% | 37% |
|
| EPS (5yr) | (1.9%) | 15.5% | 29 |
|
| Dividends (5yr) | 5.0% | 0.0% | 58% |
|
| Cash Flow (5yr) | (12.4%) | (15.8%) | 57% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MTHRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,210 | $202 | 62% |
|
| Net Income (TTM) (Mil) | $309 | ($9) | 73% |
|
| EPS (TTM) | $0.456 | ($0.600) | 53% |
|
| Operating Cash Flow (TTM) (Mil) | $442 | ($1) | 70% |
|
| Net Cash Flow (TTM) (Mil) | na | $3 | na |
|
| Long-Term Debt (Q1) (Mil) | $314 | $18 | 54% |
|
| Enterprise Value (Q1) (Mil) | na | $197 | na |
|
| Valuation | MTHRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.38 | na |
|
| P/E | na | 39.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 2.4 | na |
|
| Ratios | MTHRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 50.6% | 61.6% | 63% |
|
| Net Margin | 13.0% | (24.1%) | 69% |
|
| ROA | 8.5% | (21.8%) | 84% |
|
| ROE | 12.6% | (6.7%) | 65% |
|
| Liabilities to Assets | 29.9% | 32.1% | 21% |
|
| F-Score | na | 4 | na |
|
M3, Inc. did not pass any screens on 8/20/2026.
